Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | EDNRA | P25101 | 2/20 | 0.34 |
| ▸ | EDNRB | P24530 | 1/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.33 |
| ▸ | RAC2 | P15153 | 1/20 | 0.33 |
| ▸ | RAC3 | P60763 | 1/20 | 0.33 |
| ▸ | CDC42 | P60953 | 1/20 | 0.33 |
| ▸ | RAC1 | P63000 | 1/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22145869 | 0.93 | EDNRB (0.33) | KDM4EATML3MBTL1EDNRAEDNRB | |
| SCHEMBL22145875 | 0.93 | NPY5R (0.31) | EDNRAEDNRBNPY5R | |
| SCHEMBL15944568 | 0.91 | KDM4E (0.34) | KDM4EATML3MBTL1EDNRAEDNRB | |
| SCHEMBL12333547 | 0.90 | L3MBTL1 (0.44) | KDM4EATML3MBTL1EDNRAEDNRB | |
| SCHEMBL19035954 | 0.90 | EDNRB (0.31) | KDM4EATML3MBTL1EDNRAEDNRB | |
| SCHEMBL17471210 | 0.90 | KDM4E (0.38) | KDM4EATML3MBTL1EDNRAEDNRB | |
| SCHEMBL17278456 | 0.90 | KDM4E (0.38) | KDM4EATML3MBTL1EDNRAEDNRB | |
| SCHEMBL17278713 | 0.90 | KDM4E (0.38) | KDM4EATML3MBTL1EDNRAEDNRB | |
| SCHEMBL22146059 | 0.89 | EDNRB (0.33) | KDM4EATML3MBTL1EDNRAEDNRB | |
| SCHEMBL22145879 | 0.88 | MEN1 (0.34) | KDM4EATML3MBTL1EDNRAEDNRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3615542-B1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-08-23 | — | — | EP | disclosed |
| US-11649249-B2 | Compounds for electronic devices | MERCK PATENT GMBH (DE) | 2023-05-16 | — | — | US | disclosed |
| US-11649249-B2 | Compounds for electronic devices | MERCK PATENT GMBH (DE) | 2023-05-16 | — | — | US | disclosed |
| US-20200199154-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11649249-B2 | Compounds for electronic devices | DDT, CYP2C9, CYP2D6 | KDM4E 2128/4885ATM 2015/4885L3MBTL1 3711/4885 |
| US-20200199154-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | DDT, CYP2C9, CYP2D6 | KDM4E 2128/4885ATM 2015/4885L3MBTL1 3711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.